SAU · 4164.SR
Nahdi Medical Company
SAR 91.20+SAR 0.20 (+0.22%)
Nahdi Medical Company’s quoted price sits in the lower half of its reported 52-week range, 21.92% below the high.
Loading market information…
SAU · 2070.SR · SAR
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 12:18 PM UTC. Cached market data; not a live quote.
One-year closing-price history · SAR. Historical prices are not a forecast.
Saudi Pharmaceutical Industries and Medical Appliances Corporation’s quoted price sits in the lower half of its reported 52-week range, 17.71% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Saudi Pharmaceutical Industries and Medical Appliances Corporation’s forward annual dividend is SAR 0.60 per share, paid annual. The forward yield is 2.19% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Saudi Pharmaceutical Industries and Medical Appliances Corporation’s next earnings report is currently expected on Nov 3, 2026, with estimated earnings per share of SAR 0.27. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Saudi Pharmaceutical Industries and Medical Appliances Corporation’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Established in 1986 and headquartered in Buraydah, Saudi Arabia, Saudi Pharmaceutical Industries and Medical Appliances is dedicated to the development, manufacturing, and marketing of medicinal products and pharmaceutical formulations. Its operational footprint spans the Kingdom of Saudi Arabia, Egypt, the broader Middle East, Morocco, and Algeria. The company's extensive portfolio also includes the production of basic chemical substances, human-use medicines (including cosmetics), and the wholesale and retail distribution of pharmaceuticals and related items. Moreover, it actively develops, produces, and sells medical appliances in addition to pharmaceutical products, and undertakes the operation and maintenance of healthcare facilities. A core aspect of its mission is engaging in advanced research and development within medical science.
Latest available per-share figures in SAR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 01:22 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| May 12, 2025 |
| SAR 0.59 |
| SAR 484.84M-1.05% vs estimate |
| Q4 2024 | Mar 27, 2025 | -SAR 0.24 | SAR 386.20M-8.16% vs estimate |
|---|
| Q3 2024 | Nov 11, 2024 | -SAR 0.07 | SAR 447.02M+2.06% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
SAR 91.20+SAR 0.20 (+0.22%)
Nahdi Medical Company’s quoted price sits in the lower half of its reported 52-week range, 21.92% below the high.
SAR 119.90-SAR 2.10 (-1.72%)
Jamjoom Pharmaceuticals Factory Company’s quoted price sits in the lower half of its reported 52-week range, 26.76% below the high.
SAR 36.88-SAR 0.42 (-1.13%)
Al-Dawaa Medical Services Company’s quoted price sits in the lower half of its reported 52-week range, 43.91% below the high.
SAR 61.20+SAR 0.25 (+0.41%)
Middle East Pharmaceutical Industries Company’s quoted price sits in the lower half of its reported 52-week range, 22.0% below the high.
SAR 26.00-SAR 0.16 (-0.61%)
Scientific and Medical Equipment House’s quoted price sits in the lower half of its reported 52-week range, 34.34% below the high.
SAR 69.95SAR 0.00 (0.0%)
Alf Meem Yaa for Medical Supplies and Equipment Company’s quoted price sits in the lower half of its reported 52-week range, 39.7% below the high.
SAR 17.50SAR 0.00 (0.0%)
Arabian International Healthcare Holding Company’s quoted price sits in the lower half of its reported 52-week range, 36.41% below the high.
SAR 20.99SAR 0.00 (0.0%)
Almujtama Alraida Medical Co.’s quoted price sits in the lower half of its reported 52-week range, 33.37% below the high.
